Addiction & Substances

Benzodiazepine Addiction and Dependence: UK Guide

By Craig Bilton, Founder & Clinical Director · Updated 25 August 2026 · 23 min read

Benzodiazepines are medicines that can relieve severe anxiety, muscle spasm, seizures and some sleep problems, but they can also cause tolerance, physical dependence, withdrawal and addiction. These outcomes are related but not identical. A person can become physically dependent while taking a medicine exactly as prescribed, without compulsive use. Others develop impaired control, use non-prescribed tablets or continue despite serious harm.

The safest response is not blame and it is not abrupt stopping. It is an accurate medication and substance-use review, assessment of overdose and withdrawal risk, a clinician-led plan when reduction is appropriate, and support for the anxiety, insomnia, trauma or addictive pattern that may be maintaining use.

This guide is educational and cannot diagnose dependence or addiction, identify the contents of an illicit tablet, or provide an individual taper. Do not reduce or stop a benzodiazepine because of this article. Speak to the prescriber, a GP, pharmacist or specialist service. If someone cannot be woken, is breathing slowly, has blue lips, is having a seizure or is severely confused, call 999.

The concise answer

Benzodiazepine dependence means the body has adapted to regular exposure and withdrawal symptoms may occur if the medicine is reduced or stopped. Addiction involves a strong drive to use and difficulty controlling use despite risk or harm. Either can occur with prescribed medicines, while unregulated tablets add uncertainty about the drug and dose.

Withdrawal can be medically dangerous. NICE advises against abrupt cessation except in exceptional medical circumstances and recommends an individual, slow, stepwise reduction when withdrawal is appropriate. The plan must reflect the medicine, duration and pattern of use, previous withdrawal, other substances, physical and mental health, and available support. No single online taper is safe for everyone.

Table of contents

1. Key takeaways
2. What benzodiazepines are
3. Dependence, addiction and tolerance
4. Signs that use may be becoming a problem
5. Main risks and dangerous combinations
6. Withdrawal and urgent warning signs
7. What an assessment should cover
8. Treatment and recovery
9. Finding help in the UK
10. Practical next steps
11. Frequently asked questions

Key takeaways

• Benzodiazepines can be appropriate medicines, but prescription status does not remove the risks of tolerance, dependence, withdrawal, sedation or overdose.
• Physical dependence is not the same as addiction. Dependence can develop without compulsive behaviour; addiction involves impaired control and continued use despite harm.
• Do not stop a regularly used benzodiazepine abruptly without clinical advice. Withdrawal can include severe symptoms such as seizures, hallucinations and delirium.
• Combining benzodiazepines with opioids or alcohol can greatly increase sedation and respiratory-depression risk. Never change prescribed medicines independently; ask the prescriber or pharmacist to review the full combination.
• Tablets bought online or on the illicit market may not contain what the packaging claims. This makes strength, interactions and withdrawal exposure harder to assess.
• A safe plan starts with the exact medicine or source, pattern of use, other substances, previous withdrawal, physical and mental health, current safety and the person's goals.
• Withdrawal management is not the whole treatment. Anxiety, insomnia, trauma, coping, relationships and the circumstances maintaining use may also need evidence-based support.

What are benzodiazepines?

Benzodiazepines are central-nervous-system depressant medicines. They increase the effect of gamma-aminobutyric acid, usually called GABA, which reduces activity in parts of the nervous system. Depending on the medicine and clinical situation, they may be used for severe anxiety, acute insomnia, muscle spasm, seizures, alcohol withdrawal, procedural sedation or other specialist purposes.

Examples include diazepam, lorazepam, temazepam, nitrazepam, clonazepam and clobazam. They differ in potency, duration of action, licensed uses and how the body processes them. That matters clinically: two tablets that look similar are not interchangeable, and the same number of milligrams does not mean the same effect across different benzodiazepines.

For anxiety and insomnia, treatment is generally intended to be short term. The MHRA's 2026 patient resource says these medicines are often prescribed for periods of up to four weeks, while explicitly noting that its advice does not apply to people receiving benzodiazepines for epilepsy. Some people have valid longer-term or specialist indications. The right response to a long-standing prescription is therefore a review, not an assumption that it was wrong and not an abrupt change.

Z-drugs such as zopiclone and zolpidem are not benzodiazepines, although they have related dependence and withdrawal concerns and are included with benzodiazepines in current NICE and MHRA medicines-safety guidance. This article focuses on benzodiazepines; a prescriber should review every sedating medicine together.

Dependence, addiction and tolerance are not the same

These terms are often used as if they mean one thing. Distinguishing them reduces stigma and helps identify the right support.

Physical dependence

Physical dependence means the nervous system has adapted to the presence of the medicine. A reduction, missed doses or stopping may then produce withdrawal symptoms. Dependence can occur during legitimate treatment and does not by itself show that a person has behaved irresponsibly or has an addiction.

NICE advises clinicians to explain that dependence is an expected effect of these medicines for some people and to use language that does not blame the person. The MHRA similarly states that anyone can become physically dependent, including when a medicine is used as directed.

Addiction

Addiction is a pattern that may include a strong desire to take the drug, difficulty controlling use and continuing despite harm. It may involve taking more than intended, obtaining tablets from several or unregulated sources, using for intoxication or emotional escape, or repeatedly returning to use after serious consequences.

Someone can have both addiction and physical dependence, but not everyone with dependence has addiction. A diagnostic assessment looks at behaviour, control, consequences and functioning, not only the dose or duration.

Tolerance

Tolerance means the same amount appears to have less effect over time, or a person feels they need more for the previous effect. Tolerance can be a warning sign, but increasing the dose without a prescriber can add risk and may not restore lasting benefit. The MHRA's strengthened 2026 warnings ask clinicians and patients to discuss tolerance alongside addiction, dependence and withdrawal.

Withdrawal

Withdrawal is the collection of symptoms that can follow dose reduction, missed doses or stopping after the body has adapted. Symptoms may overlap with the original anxiety or insomnia, which can make the situation confusing. Timing, pattern and clinical review help distinguish withdrawal, rebound symptoms, recurrence of the original condition and a new problem.

Signs that benzodiazepine use may be becoming a problem

No single sign proves addiction. A medication review is worthwhile when one or more patterns are present, especially if they are increasing:

• needing the medicine more often or feeling that the previous amount no longer works
• taking extra doses, using earlier than planned or running out before the next prescription
• using for reasons other than the agreed clinical purpose, such as emotional numbing or intoxication
• repeatedly trying to reduce but returning to the previous pattern because of symptoms or cravings
• spending substantial time obtaining, using or recovering from tablets
• seeking prescriptions from several clinicians or buying tablets online or through the illicit market
• continuing despite falls, memory problems, work errors, relationship conflict, debt, driving risk or medical warnings
• mixing with alcohol, opioids, gabapentinoids, sedating antihistamines or other depressants
• feeling unable to cope, sleep, leave home or function without a dose
• anxiety, tremor, insomnia, sensory sensitivity or other symptoms after a missed or reduced dose
• concealing the extent or source of use from family or healthcare professionals.

These signs should prompt curiosity, not accusation. Some may reflect undertreated anxiety, pain, insomnia, trauma, medicine side effects or fear of withdrawal. A whole-person review can separate immediate safety from the longer-term formulation.

The addiction warning signs guide explains impaired control and continued use despite harm in more detail. If mental-health symptoms and benzodiazepine use are interacting, see our mental health and addiction guide.

The main risks of benzodiazepines

Risk varies with the medicine, amount, duration, age, health conditions and other substances. A person should read the patient information leaflet for their exact medicine and ask a pharmacist or prescriber about individual concerns.

Sedation, coordination and memory

Benzodiazepines may cause sleepiness, reduced alertness, slowed speech, poor coordination, memory difficulty and confusion. These effects can contribute to falls, accidents, unsafe work and impaired driving. NHS advice for diazepam says not to drive, cycle or use tools or machinery while sleepy or otherwise affected. Being prescribed a medicine does not make it safe to drive while impaired.

Older people, people with breathing or liver problems and those taking several sedating medicines may need particular review. Do not make independent changes; ask a clinician or pharmacist to assess the complete regimen.

Opioids, alcohol and other depressants

The most dangerous combinations are those that add central-nervous-system depression. The MHRA warns that benzodiazepines and opioids can have additive effects that increase sedation, respiratory depression, coma and death. Alcohol and other sedatives can also intensify impairment.

If a benzodiazepine and opioid have both been prescribed, do not suddenly stop either medicine because of this warning. Contact the prescriber or pharmacist promptly for a coordinated review. Do not add alcohol, non-prescribed opioids, street tablets or extra sedatives. If opioid exposure is possible, ask a local drug service about naloxone; naloxone reverses opioid effects, not a benzodiazepine-only overdose, but may save a life when the substances are uncertain or combined.

Overdose and drug-poisoning deaths

In England and Wales, the Office for National Statistics recorded diazepam on 302 drug-poisoning death certificates registered in 2024. This does not mean diazepam alone caused every death: several substances may be mentioned, the data concern registrations rather than the year the death occurred, and specific drug information is not available for every case. The figure does show why benzodiazepine exposure must be considered alongside opioids, alcohol and other depressants.

Illicit and counterfeit benzodiazepines

Tablets sold as diazepam, alprazolam or another familiar medicine may be counterfeit or contain a different novel benzodiazepine. Packaging and appearance cannot confirm contents or strength. Public Health Scotland notes that street benzodiazepines may be sold in counterfeit branded packaging or as loose pressed pills, and the Advisory Council on the Misuse of Drugs has documented newly encountered compounds in UK and international markets.

This uncertainty increases overdose and withdrawal risk. Tell the clinician honestly where tablets came from and show packaging or photographs if it is safe to do so. Do not assume an illicit tablet is equivalent to a prescription dose.

Benzodiazepine withdrawal and why abrupt stopping is unsafe

Regular benzodiazepine use can lead to withdrawal when the amount falls. The exact experience cannot be predicted from an article. It depends on factors including the specific medicine, how long and how regularly it has been used, dose, half-life, previous withdrawal, other medicines, alcohol or drug use, physical health, mental health and individual sensitivity.

Possible symptoms include:

• anxiety, panic, agitation or irritability
• insomnia, vivid dreams and fatigue
• sweating, tremor, palpitations and dizziness
• headache, muscle pain or stiffness
• nausea, appetite change or abdominal symptoms
• difficulty concentrating, memory problems or feeling detached from reality
• increased sensitivity to light, sound, touch or other sensations
• perceptual disturbance, hallucinations or paranoia
• confusion or delirium
• seizures.

Seizures, hallucinations, severe confusion and delirium are medical emergencies. Withdrawal symptoms can begin quickly with some shorter-acting medicines and later with longer-acting medicines. NICE notes that symptoms may be delayed, may change over time and, for some people, may persist for months or longer. A fixed internet timeline can therefore create false reassurance or unnecessary alarm.

Do not use a generic taper from the internet

NICE recommends shared decision-making and, when withdrawal is appropriate, a slow, stepwise rate that is proportionate to the current dose, with smaller reductions as the dose becomes lower. It also says the schedule may need to change if symptoms become intolerable and should be reviewed regularly.

Those principles are intentionally individual. This article does not provide percentages, tablet conversions or a calendar because a safe plan requires prescribing responsibility and clinical information. An unregulated supply creates additional uncertainty and may require specialist assessment before a stable plan can be agreed.

Do not stop a prescribed benzodiazepine, substitute one benzodiazepine for another or alter several dependence-forming medicines at once without professional advice. People taking benzodiazepines for epilepsy or another specialist indication should contact their specialist team or prescriber.

For the broader safety principles, read Addiction Detox in the UK. IRN's detox suitability assessment is educational and cannot decide a withdrawal regimen or replace medical assessment.

When to get urgent help

Call 999 or go to A&E if someone who has taken benzodiazepines or may be withdrawing:

• cannot be woken or loses consciousness
• has blue or grey lips, slow, shallow, noisy or stopped breathing
• has a seizure
• is severely confused, delirious or hallucinating
• has collapsed, sustained a serious injury or may have taken an overdose
• is at immediate risk of suicide, self-harm or harming another person.

Place an unconscious but breathing person in the recovery position if you know how, call 999 and follow the call handler's instructions. Do not make them vomit or give them food or drink. Stay with them, keep checking their breathing and tell emergency staff what may have been taken, including alcohol, opioids and prescribed medicines. Bring packaging if it is safe.

For more than the prescribed diazepam dose without immediate life-threatening symptoms, current NHS advice is to call 111. If breathing, consciousness or seizure risk is uncertain, call 999. Routes outside England differ; use the urgent NHS or health-service pathway for the nation where the person is located.

Urgent symptoms take priority over concerns about whether the tablets were prescribed or obtained illegally.

What a benzodiazepine assessment should cover

A safe assessment is factual, non-judgemental and specific. It should not start and end with “How many tablets?” because potency and source may be uncertain.

Expect questions about:

• The medicine or tablet: name, strength, formulation, appearance, source, reason for use and whether it was prescribed.
• Pattern: amount, frequency, timing, missed doses, last use, duration, periods of escalation and any binge pattern.
• Other depressants: opioids including methadone or buprenorphine, alcohol, Z-drugs, pregabalin or gabapentin, sedating antihistamines and other prescribed or non-prescribed medicines.
• Withdrawal history: anxiety, insomnia, tremor, hallucinations, delirium or seizures; previous attempts to reduce; what helped or made symptoms worse.
• Overdose history: loss of consciousness, naloxone use, ambulance attendance, injuries and whether substances were combined.
• Physical health: breathing conditions, sleep apnoea, liver or kidney problems, pregnancy, pain, falls, head injury and seizure disorders.
• Mental health: anxiety, panic, insomnia, depression, trauma, psychosis, suicidal thoughts and why benzodiazepines are currently serving a function.
• Function and safety: driving, machinery, caring for children or vulnerable adults, work, housing, relationships, money, exploitation and safe medicine storage.
• Treatment context: every prescriber, pharmacy, specialist, drug service and current medicine; what was originally agreed and what has changed.
• Goals and support: whether the person wants safer use, stabilisation, reduction or eventual cessation; previous strengths; trusted people; and practical barriers to follow-up.

A clinician may need physical observations, toxicology or other investigations, but tests do not replace the history. With consent, communication between the GP, prescriber, pharmacist, mental-health team and drug service can reduce fragmented or duplicated prescribing.

NICE says risks such as a mental-health condition, previous drug or alcohol misuse or concurrent opioid treatment should be discussed, but a medicine should not be withheld solely because one risk factor is present. The same non-stigmatising approach should continue when problems develop.

What treatment and recovery can involve

There is no single “benzodiazepine rehab” pathway. Care should separate immediate medical risk, physical dependence, addictive behaviour and the original reason for use, then coordinate them.

Medication review and withdrawal planning

For someone using a prescribed benzodiazepine, the original prescriber, GP or another appropriately qualified clinician should review benefit, harms, current use and alternatives. Withdrawal may be discussed when the medicine is no longer helping, the original condition has resolved, dependence-related problems have developed, harms outweigh benefits or the person wants to stop.

The first goal is not always complete withdrawal. NICE recognises that dose reduction with continuing review may be a more realistic initial aim for some people. The pace can vary and may take months or longer. A plan should state who prescribes, how often progress is reviewed, what symptoms require contact and what happens if risk increases.

Community, inpatient or residential care

Many people can be assessed and supported in the community by a GP, prescribing service or local drug and alcohol team. Greater medical structure may be needed when there is:

• a history of withdrawal seizures, delirium or severe symptoms
• high or uncertain exposure, especially from unregulated tablets
• concurrent alcohol, opioid or multiple-depressant dependence
• repeated overdose or loss of consciousness
• unstable physical or mental health
• pregnancy, significant respiratory illness or another complex medical condition
• serious suicide risk, psychosis, safeguarding concerns or an unsafe home environment
• inability to follow or store a prescription safely.

Residential accommodation alone does not prove that medical withdrawal can be managed safely. Ask who holds prescribing responsibility, how the service assesses uncertain street-tablet exposure, what overnight clinical cover exists and where emergency transfer occurs. Treatment placement should verify capability rather than rely on marketing language.

Psychological and recovery support

Withdrawal management changes the medicine exposure; it does not automatically change the reasons a person relies on it. Treatment may also include:

• motivational work and collaborative goal-setting
• cognitive behavioural or other evidence-based therapy for anxiety or insomnia
• trauma-informed support where trauma is relevant
• relapse-prevention planning for cravings, triggers and access to tablets
• support with sleep routine, stress, relationships, pain and daily structure
• peer or mutual-aid support where the person finds it useful
• family involvement with consent and separate support for relatives
• treatment for co-occurring alcohol, opioid or other drug problems
• continuing mental-health care and medication review.

IRN's online recovery programme may provide structured recovery support for suitable, medically stable adults after clinical withdrawal risk has been addressed. It is not a medical detox service and should not replace a prescriber, urgent care or local clinical monitoring.

Harm reduction while waiting for care

The safest advice depends on what is prescribed and what has been used. General protective steps include not taking more than prescribed, not sharing medicines, storing them away from children, not driving while impaired and avoiding alcohol or non-prescribed depressants. If prescribed combinations are a concern, obtain an urgent medication review rather than changing them independently.

Someone using unregulated tablets should tell the service this directly. Local drug services can discuss overdose prevention, naloxone where opioid exposure is possible, safer storage and routes into treatment. Harm reduction is not approval of continued use; it is a way to reduce the chance of death or serious injury while treatment is arranged.

How to find benzodiazepine help in the UK

Your prescriber, GP or pharmacist

If the benzodiazepine was prescribed, contact the prescriber or GP and request a medication review. A pharmacist can explain the supplied medicine, interactions and urgent routes, and can help clarify who should coordinate the prescription. Bring an accurate list of all prescribed, over-the-counter and non-prescribed substances.

Do not avoid the appointment because some tablets were obtained elsewhere. Clinicians need the real pattern to assess breathing, overdose and withdrawal risk.

Local drug and alcohol services

NHS guidance says people are entitled to treatment for a drug problem as for any other health problem. A GP can refer, and many local drug services accept self-referral. Assessment commonly includes drug use, health, work, family and housing, followed by an agreed treatment plan and keyworker support.

Service directories differ across the four nations. In England, use the NHS drug-support page or FRANK service finder. In Scotland, NHS inform provides benzodiazepine safety information and local alcohol and drug service routes. In Wales, use NHS Wales or DAN 24/7. In Northern Ireland, use the Public Health Agency's local drug and alcohol service information. Call 999 for an emergency wherever you are.

Private treatment

Private care may offer additional choice or faster access, but verify:

1. who performs the medical assessment and holds prescribing responsibility
2. which clinicians are professionally registered
3. how the provider handles epilepsy, pregnancy, respiratory illness and mental-health risk
4. how prescribed and unregulated tablets are identified and documented
5. how opioid, alcohol and multi-drug risk is managed
6. whether overnight monitoring and emergency transfer are available
7. how the provider coordinates with the GP, pharmacy and NHS teams
8. what psychological treatment and aftercare follow withdrawal management
9. what is included in the fee and what requires external medical care
10. how outcomes, incidents and complaints are governed.

Be cautious if a provider promises a universal rapid detox, publishes one taper for everyone, guarantees a symptom-free withdrawal or cannot name the responsible prescriber.

What to do today if you are concerned

If there is no immediate emergency, a few practical actions can make the next assessment safer.

1. Do not stop abruptly

Keep taking a prescribed medicine as directed until you have professional advice, unless an emergency clinician tells you otherwise. Do not copy a taper from social media, a forum or another person's prescription.

2. Write down the complete picture

Record the exact prescribed medicine and dose, any tablets from other sources, how often they are used, last use, other medicines, alcohol or drugs, previous withdrawal symptoms and current concerns. If the contents are unknown, say so rather than estimating certainty.

3. Contact the right service

Start with the prescriber, GP, pharmacist or local drug service. Explain early in the conversation if there has been a seizure, overdose, opioid or alcohol combination, pregnancy, serious mental-health risk or a supply of uncertain tablets.

4. Reduce immediate environmental risk

Store medicines securely and do not share them. Do not drive or use machinery while drowsy, confused or uncoordinated. Keep emergency numbers available. Where opioid exposure is possible, ask a drug service about naloxone and overdose response.

5. Arrange follow-up, not just one conversation

Leave the appointment knowing who holds prescribing responsibility, the next review date, whom to contact if symptoms change and what requires urgent help. Withdrawal and recovery plans often need adjustment.

How families can help

Relatives may notice sedation, memory problems, early prescription use, online purchasing, falls, missed responsibilities or withdrawal symptoms. Raise concerns when the person is alert and the situation is calm. Describe specific observations rather than applying a label: “You have fallen twice and seemed difficult to wake” is more useful than “You are an addict”.

Do not hide, discard or suddenly remove a dependent person's tablets. That can trigger withdrawal and drive unsafe sourcing. Encourage a professional review, offer to help prepare the medicine list and, with consent, attend appointments. Call emergency services for overdose, seizure, severe confusion or immediate danger.

Families also need boundaries. Do not give money for unregulated tablets, share your own medicine or take responsibility for managing a taper. Our addiction support for families guide covers communication, safety, confidentiality and support for your own wellbeing.

When professional support is needed

Arrange a medication or substance-use assessment when benzodiazepines are being taken regularly, the effect is changing, doses are escalating, tablets come from several sources, attempts to reduce have failed, withdrawal symptoms occur or use is affecting health, work, relationships, money, memory or safety.

Seek help sooner when there is opioid or alcohol use, pregnancy, epilepsy, breathing illness, repeated falls, overdose history, severe mental illness, suicidal thoughts, psychosis, safeguarding risk or unregulated tablets of uncertain strength.

Asking for help does not commit someone to abrupt withdrawal or residential treatment. It creates the information needed to choose a proportionate and safer next step.